Cardiovascular involvement in multisystem inflammatory syndrome in children and midterm follow-up from a pediatric

Poovazhagi Varadarajan1, Ritchie Sharon Solomon2, Seenivasan Subramani1

  • 1Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil Nādu, India.

Insights

Most children with multisystem inflammatory syndrome in children (MIS-C) experienced cardiovascular issues, requiring intensive care. While shock resolved rapidly, ventricular and coronary abnormalities persisted, necessitating long-term follow-up for pediatric MIS-C patients.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Limited data exists on cardiovascular involvement in multisystem inflammatory syndrome in children (MIS-C) from low- and middle-income countries.
  • Understanding the longitudinal outcomes of cardiovascular complications in MIS-C is crucial.

Purpose of the Study:

  • To investigate the pattern of cardiovascular involvement in children diagnosed with MIS-C.
  • To determine the mid-term outcomes of cardiovascular complications in MIS-C.
  • To identify associations between cardiovascular abnormalities and clinical/laboratory parameters.

Main Methods:

  • A prospective study enrolled 270 children with MIS-C from June 2020 to January 2022.
  • Echocardiography and laboratory tests were performed at admission, with follow-ups at 2 weeks, 3 months, 6 months, and 1 year.
  • Multivariate regression analysis was used to identify risk factors for cardiovascular involvement and dysfunction.

Main Results:

  • Cardiovascular involvement was observed in 78.2% of patients, with shock (45.6%), coronary aneurysm (28.5%), and left ventricular dysfunction (29.3%) being common.
  • Breathlessness and high-flow nasal cannula support predicted cardiovascular involvement.
  • Anemia was a risk factor for coronary involvement, while altered sensorium and invasive ventilation predicted shock.

Conclusions:

  • A significant proportion of children with MIS-C exhibit cardiovascular involvement, leading to increased ICU admissions.
  • While shock resolved quickly, ventricular function and coronary abnormalities showed slower resolution.
  • Structured long-term follow-up protocols are essential for managing cardiovascular sequelae in pediatric MIS-C.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
361
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
496
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
400
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548